Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and Minocycline Quadruple Therapy for H. pylori
NCT06603688Phase 4Unknown
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of berberine and minocycline in Helicobacter pylori infection (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Helicobacter pylori eradication rates. Status: unknown.
02
Drugs
berberineminocycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06603688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06603688.